FDA Proposes Requiring Unit-Dose Packaging For Orally Disintegrating OTC Monograph Drugs

Separate Proposal Would Make Change Easier To Swallow

CDER Office of Nonprescription Drugs' proposed order for individual packaging requirements for would establish OTC monograph condition B001. (Source: FDA/Citeline)
HBW Podcast

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

More from Policy & Regulation

More from HBW Insight